💊

Week 12 Supplemental Resources: Drug-Nutrient Interactions Linus Pauling Institute

Apr 11, 2025

Drug-Nutrient Interactions

Overview

  • Drug-nutrient interactions are significant but not systematically studied.
  • Interactions may affect the kinetic/dynamic parameters of drugs or nutrients by 20% to be considered clinically significant.
  • Long-term drug use often required to reach clinically significant interaction levels.

Common Interactions

Alcohol

  • Folate, Riboflavin, Thiamin, Vitamin A, B6
    • Chronic alcohol abuse can lead to deficiencies due to low dietary intake, decreased absorption, or increased excretion.
    • Actions: Ensure adequate intake or supplement to prevent deficiencies.

Antacids

  • Folate, Fluoride, Iron, Magnesium, Manganese, Phosphate
    • Can impair absorption of nutrients due to altered gastrointestinal pH.
    • Actions: Separate intakes by a few hours to mitigate interaction.

Aspirin

  • Vitamin C, Vitamin E
    • May cause increased excretion of Vitamin C and interact with Vitamin E.
    • Actions: Ensure adequate Vitamin C intake, avoid high-dose Vitamin E with aspirin.

Bisphosphonates

  • Calcium, Iron, Magnesium, Zinc
    • Concomitant intake can decrease absorption due to complex formation.
    • Actions: Separate by 2 hours to ensure proper absorption.

Carbamazepine

  • Biotin
    • May inhibit absorption and increase catabolism.
    • Actions: Monitor biotin status, especially with long-term use.

Cholestyramine

  • Folate, Fat-soluble vitamins (A, D, E, K)
    • May bind and decrease absorption, increasing deficiency risk.
    • Actions: Supplementation and separating intake times recommended.

Metformin

  • Vitamin B12
    • Interferes with absorption, possible deficiency risk.
    • Actions: Monitor B12 status.

Phenytoin

  • Folate, Thiamin, Vitamin D, Vitamin K
    • Can decrease absorption or increase excretion, leading to deficiencies.
    • Actions: Supplementation may be necessary.

Warfarin

  • Vitamin K, Vitamin E, Vitamin C
    • Interactions affecting coagulation.
    • Actions: Monitor intake to ensure stable INR, avoid large fluctuations.

Special Considerations

  • Grapefruit: Inhibits CYP3A4, increasing drug bioavailability and risk of toxicity.
  • Herbs/Supplements: Many herbs can interact with drugs like warfarin, requiring careful monitoring.

Recommendations

  • Separate nutrient and drug intakes by a few hours to reduce interaction risk.
  • Monitor patients' nutritional status regularly, especially during long-term drug therapy.
  • Consider supplementation for at-risk nutrients when interactions are known.